News

In this series of articles, we look back at the highlights of the parallel sessions that were organized at this year’s Lygature Partnerships Meetup

Jon de Vlieger, Director of Business Development and Coordinator of the Non-Biological Complex Drugs (NBCD) Working Group at Lygature, was invited to present at two high-profile international meetings, where he shared his views on regulations for complex drug products. Read more in his blog below.

After speaking at the Global Summit on Regulatory Science 2019 in September, Jon de Vlieger, our Director Business Development and Coordinator of the NBCD Working Group, will also be presenting at the American Association of Pharmaceutical Scientists (AAPS) 2019 PharmSci 360 conference in San Antonio, Texas, on November 4.

Do you believe in the power of partnerships to address unmet medical needs? Are you passionate about the wider applications of science?

The Trials@Home consortium will explore the opportunities of moving clinical trials from the traditional clinic setting to the participant's immediate surroundings.

At this year’s Health-RI conference on January 30th 2020 at the Jaarbeurs Supernova in Utrecht, leading experts will highlight how data is helping us to remain healthy, and how it can drive us towards a healthy future.

Immune-Image has been awarded a 30 million Euro grant for research into novel tracer strategies for clinical imagining of immune cell dynamics and has officially launched on October 1 2019.

The Patient & Public Advisory Council of BBMRI-NL is looking for an enthusiastic and committed Chair; someone that can represent the diversity of the Council and will enable her to further increase impact.

Radboudumc announced the discovery of an innovative new drug candidate against malaria. The molecule, designed to cure a skin disease, has shown particular effectiveness against malaria. A single dose appears to cure the disease completely.

The global threat of AMR can only be curbed by collaborative efforts.

On July 1st, a new partnership launched in the fight against antimicrobial resistance. GNA NOW (Gram-Negative Antibacterials NOW) will work on the development of novel antibacterial agents against antimicrobial resistance in gram-negative bacteria.

GNA NOW (Gram-Negative Antibiotic NOW) started on July 1st under the AMR Accelerator umbrella

Where do you start when you want to set up a research consortium? And, once the partnership is up and running, how do you make sure it turns into a success? These and other questions were discussed by Wim-Jan Koot, director Business Development at Lygature, during ZonMw’s personalized medicine event.

The Lygature team is proud to announce our fourth annual Partnerships MeetUp! Join us in Utrecht on October 29th for inspiring keynotes, interactive parallel sessions and lots of networking.

Dr Jon de Vlieger (Lygature’s Senior Business Developer) and Dr Remco de Vrueh (Lygature’s Senior Program Manager), together with professor Daan Crommelin (past vice-chair of the scientific advisory board of the Innovative Medicines Initiative) wrote on invitation the editorial of the scientific journal Frontiers in Medicine.